Research News and Research

RSS

Full genetic blueprint of multiple prostate tumors laid bare

For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease. The study, made possible by key advances in whole genome sequencing and analysis, points to several new prostate cancer genes and a critical category of genomic changes as important drivers of prostate cancer growth.

10 Feb 2011

LabCorp fourth quarter net earnings decrease to $131.8 million

Laboratory Corporation of America® Holdings today announced results for the quarter and year ended December 31, 2010. These results include the operations of Genzyme Genetics for the month of December.

10 Feb 2011

TMJ Medical receives FDA postmarket surveillance study order

TMJ Medical acknowledged Tuesday receiving a postmarket surveillance study order from the U.S. Food and Drug Administration. TMJ Medical is one of three medical device manufacturers approved to market temporomandibular joint (TMJ) implants in the United States. Each manufacturer received the same FDA order.

10 Feb 2011

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

BioCryst Pharmaceuticals, Inc. announced financial results for the fourth quarter and full year ended December 31, 2010.

10 Feb 2011

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

As a nationally recognized healthcare organization, home to one of the most advanced vascular interventional practices in the country, Terrebonne General Medical Center (TGMC) handles approximately 3,300 cath lab patients annually. Patients from all over the country come to TGMC for interventional treatment for conditions associated with cardiovascular disease (CVD) and peripheral vascular disease (PVD), including limb ischemia.

10 Feb 2011

Vical 2010 net loss increases to $30.4 million

Vical Incorporated today reported financial results for the year ended December 31, 2010. Vical had cash and investments of approximately $61 million at year-end 2010. The company received approximately $37 million of net proceeds from the sale of equity securities during 2010.

10 Feb 2011

Women with high folic acid levels may impact child's risk of developing asthma

Recent Norwegian research suggests that there may be a connection between high levels of folic acid in pregnant mothers and the development of asthma in their children. However, the researchers stress that pregnant women should continue to take folic acid supplements.

10 Feb 2011

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

10 Feb 2011

Alexion acquires investigational therapy for MoCD Type A ultra-rare genetic disorder from Orphatec

Alexion Pharmaceuticals, Inc. announced that it has purchased patents and assets from Germany-based Orphatec Pharmaceuticals GmbH related to an investigational therapy for patients with molybdenum cofactor deficiency (MoCD) Type A, a devastating ultra-rare genetic disorder characterized by severe brain damage and rapid death in newborns.

10 Feb 2011

Resources attributable to career, family-related choices set women back in science, technology fields

It's an incendiary topic in academia - the pervasive belief that women are underrepresented in science, math and engineering fields because they face sex discrimination in the interviewing, hiring, and grant and manuscript review processes.

10 Feb 2011

People with heart health issues, no insurance can benefit from Californians for Patient Care's online tool

People with heart health issues and little or no insurance can still get the preventive and maintenance care they need, by finding local no- and low-cost healthcare resources on Californians for Patient Care's MyHealthResource. The online tool, the only one of its kind in California, is free and confidential.

10 Feb 2011

Phospholipid membranes demonstrate ability to absorb lanthanum cations

University of Granada scientists and the Spanish Higher Institute for Scientific Research (CSIC) have made significant progress in understanding lipid membranes, which are extensively employed in the development of cosmetic and drug products, and which have potential application in the field of nanotechnology.

10 Feb 2011

House Appropriations Committee approves $32B budget cut, reducing foreign aid, domestic spending for FY11

The House Appropriations Committee "voted, 27-22, Tuesday evening to move ahead with Republican plans for cutting" $32 billion "from domestic and foreign aid spending over the last seven months of this fiscal year," Politico reports (Rogers, 2/8).

10 Feb 2011

FDLI's new Policy Forum takes close look on emerging health care liability issues

The ability of families to sue vaccine producers for faulty design could lead to a rise in litigation and force manufacturers to abandon the market, which, in turn, could cause disastrous public health consequences in the United States, assert Daniel J. Gage, Assistant Director and Alison R. Perencevich, Legislative Assistant, at the American Academy of Pediatrics' Department of Federal Affairs.

10 Feb 2011

Indiana University creates Institute for Personalized Medicine

Indiana University has announced a major commitment to research in one of health care's most promising fields with the creation of the Indiana Institute for Personalized Medicine.

10 Feb 2011

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

Research by the American Academy of Family Physicians demonstrates that vulvar cancer occurs most frequently in women age 65 to 75 years of age. Thirty percent of patients with vulvar cancer are age 70 or older, and the rate increases with age, reaching a peak of 20 per 100,000 women by 75 years of age.

10 Feb 2011

New article provides roadmap for imaging manufacturers to navigate US reimbursement environment

A new article in the February issue of the Journal of the American College of Radiology provides a roadmap for imaging manufacturers to navigate the unique and increasingly complex U.S. regulatory and reimbursement environment. "Evidence Requirements for Innovative Imaging Devices: From Concept to Adoption," identifies and addresses the five phases of an imaging procedure's lifecycle and the distinct clinical evidence needs for each phase.

10 Feb 2011

Avian flu vaccine stockpiled in 2004 still useful

A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.

10 Feb 2011

PRA opens new offices in Israel, Ukraine to meet increased demand for services

PRA International, a leading Clinical Research Organization, announces the opening of new offices in Israel and the Ukraine to accommodate the firm's continued global expansion and enhance our offerings for clients.

10 Feb 2011

Brain reacts differently to fructose compared with another common sweetener, glucose

The dietary concerns of too much fructose is well documented. High-fructose corn syrup has become the sweetener most commonly added to processed foods. Many dietary experts believe this increase directly correlates to the nation's growing obesity epidemic. Now, new research at Oregon Health & Science University demonstrates that the brain - which serves as a master control for body weight - reacts differently to fructose compared with another common sweetener, glucose.

10 Feb 2011

Research News and Research

Full genetic blueprint of multiple prostate tumors laid bare

LabCorp fourth quarter net earnings decrease to $131.8 million

TMJ Medical receives FDA postmarket surveillance study order

BioCryst reports net loss of $9.1M for fourth quarter 2010 vs. $15.2M net income for fourth quarter 2009

TGMC installs third Toshiba Infinix DP-i system with Next Generation Advanced Image Processing

Vical 2010 net loss increases to $30.4 million

Women with high folic acid levels may impact child's risk of developing asthma

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion acquires investigational therapy for MoCD Type A ultra-rare genetic disorder from Orphatec

Resources attributable to career, family-related choices set women back in science, technology fields

People with heart health issues, no insurance can benefit from Californians for Patient Care's online tool

Phospholipid membranes demonstrate ability to absorb lanthanum cations

House Appropriations Committee approves $32B budget cut, reducing foreign aid, domestic spending for FY11

FDLI's new Policy Forum takes close look on emerging health care liability issues

Indiana University creates Institute for Personalized Medicine

Study: 30% of older patients with vulvar cancer die from treatment complications, ICD

New article provides roadmap for imaging manufacturers to navigate US reimbursement environment

Avian flu vaccine stockpiled in 2004 still useful

PRA opens new offices in Israel, Ukraine to meet increased demand for services

Brain reacts differently to fructose compared with another common sweetener, glucose

Spectroscopy Applications in the Environment eBook eBook

Latest eBooks

New horizons in drug discovery: High-throughput & target-to-therapy advances

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology